Neogenomics (NEO) Inventory Average (2011 - 2026)

Neogenomics (NEO) has 16 years of Inventory Average data on file, last reported at $28.5 million in Q2 2026.

• Quarterly Inventory Average fell 10.9% year-over-year to $28.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $28.5 million (down 10.9% YoY) and the FY2025 annual result came in at $27.7 million, up 8.66% from the prior year.
• Inventory Average retreated to $28.5 million in Q2 2026, from $29.2 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $32.0 million in Q2 2025 to a low of $21.8 million in Q2 2024.
• A 5-year average of $25.7 million and a median of $24.4 million in 2023 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2024 — Inventory Average retreated 11.83% — and 2025, when it surged 46.88%.
• Tracing NEO's Inventory Average over 5 years: stood at $24.0 million in 2022, then gained by 0.28% to $24.1 million in 2023, then increased by 6.21% to $25.6 million in 2024, then increased by 11.37% to $28.5 million in 2025, then slipped by 0.09% to $28.5 million in 2026.
• The last three Inventory Average figures came in at $28.5 million (Q2 2026), $29.2 million (Q1 2026), and $28.5 million (Q4 2025), per Business Quant data.